Global race on for vaccine development to tackle rare Ebola species

▤ Summary

Global teams are racing to develop vaccines for the Bundibugyo strain of Ebola, including efforts from IAVI, the University of Oxford, and Moderna. The outbreak began in the Democratic Republic of the Congo and has spread into Uganda, with WHO tracking suspected and confirmed cases. Kenya has approved a U.S. quarantine facility plan, which triggered local protests and raised community concerns. The article also notes a U.S. national who tested positive after exposure in the DRC and was transferred to Germany for treatment.

▦ Linked Companies